Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Affordable Care Act
    • Consumer-Driven Health Care
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Drug Prices & Regulations
    • Health Economics & Costs
    • Health Insurance
    • Health Reform
    • Medical Tourism
    • Medicare
    • Single-Payer/Medicare-for-All
    • Telemedicine
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Drug Prices & Regulations

Why Fentanyl Can Kill So Easily

Posted on September 20, 2023 by Devon Herrick

Hardly a day goes by but what I read about a fentanyl overdose. I’ve also noticed an increased number of news articles about people from the entertainment industry dying unexpectedly. I always assume unexpected deaths among otherwise healthy people are drug related. According to the National Safety Council, more than 67,000 people died of fentanyl overdoses in 2021.

+

Wednesday Links

Posted on September 20, 2023September 20, 2023 by John C. Goodman
  • Covid booster tested mice – what we know.
  • The cost of Biden’s attempts to undo Trump’s deregulations: 15.3% of household income for the bottom one-fifth of the income distribution, but only 2.2% for the top fifth.
  • Gene Steuerle: it’s not clear there has been any slow down in the growth of health care spending.
  • Over the last half-century or so, the median household has seen income gains of less than 1% per year.
+

Conspiracy Between Drug Companies and PBMs Inhibit Generic Competition

Posted on September 19, 2023 by Devon Herrick

Last year the state of Tennessee health plan paid $62,000 apiece for 775 patients who were on the biologic drug Humira. Humira is used for autoimmune and inflammatory conditions like rheumatoid arthritis, Crohn’s disease and others. All told Tennessee spent nearly $50 million on one drug. This is a lot of money for only 775 patients. What is even more amazing is that nine (9) different new drugs biosimilar to Humira just hit the market. The lowest price for a generic copy is $994 a month. That is shy of $12,000 a year, or about $50,000 a year cheaper than Humira.

+

Monday Links

Posted on September 18, 2023September 18, 2023 by John C. Goodman
  • GAO: unemployment insurance fraud during the pandemic as high as $135 billion. (That is roughly $1,350 for every household in America.)
  • Medicare targets cheap, generic, life saving drug for price “negotiation.”  (WSJ)
  • Rich countries get quality medicines; the poor sometimes get poison. But, contra NYT, the solution is markets, not regulation.
  • Court tells the FDA to stop playing doctor. (WSJ)
  • As a percent of income, lower-income people cheat more on their income taxes than higher income people. HT: David Henderson
  • Did the  eradication of hookworms cause modern allergies?
+
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 77
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 15 other subscribers

Popular Topics

©2023 The Goodman Institute Health Blog | Website by Lexicom